Dr. Reddy’s Laboratories Ltd. on Thursday announced the launch of Toripalimab in India. According to company’s statement, Toripalimab is a...
Cancer
Dr Reddy's Laboratories on Wednesday announced the launch of toripalimab, an immune oncology drug to treat adults with a rare...
A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous...
A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk...
Key takeawaysSome treatments for cancer, including chemotherapy, radiotherapy, immunotherapy and hormonal therapies can affect the heart.Different cancer treatments can cause...
News ReleaseWednesday, September 18, 2024 NIH-supported clinical trial is the first positive trial for treatment of hereditary hemorrhagic telangiectasia.A clinical...